Concentration of cytokines in the serum of guinea pigs in each group. by Fangwei Xu (11845586)

Subjects:

Changes in average BD, PD, and TP of rhizosphere soil (0–60 cm) under different treatments before and after the experiment. by Hongyi Pan (5706971)

Subjects:

S8 Data - Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases by Feng Gao (3548)

Subjects:

Histopathologic inflammation grading scores of guinea pig lungs in each group. by Fangwei Xu (11845586)

Subjects:

qRT-PCR analysis of identified hub DEGs. by Zeyu Jiang (5094320)

Subjects:

Flow diagram of different experiments and the study process. by Omid Mehrpour (9385929)

Subjects:

The representative histological images of rat deep partial-thickness burns after 10 and 21 days of treatment with silver sulfadiazine 1% (SSD), opium 0.05% (OP0.05%), opium 0.5% (O... by Omid Mehrpour (9385929)

Subjects:

Table 1_Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study.docx by Lin Tao (4236)

“…After 12 weeks and 24 weeks of treatment, patients in all three groups showed a significant decrease in 24 h proteinuria from baseline (P < 0.05). …”

Survival function analysis of mortality for Viral load status and Treatment Interruption status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Multivariate Cox proportional hazard analysis ratio of patient factors associated with treatment outcomes in HIV care, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis of treatment Interruption for Viral load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis of viral suppression for BMI status and Treatment Interruption status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Schematic presentation of sampling of population for analysis. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of mortality and viral load suppression by demographic characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of ART treatment interruption and LTFU by clinical characteristics <i>among participants in HIV care Facilities in</i> Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of ART treatment interruption and LTFU by demographic characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Incidence of mortality and viral load suppression by clinical characteristics among participants in HIV care facilities in Bauchi State, 2020-2022. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Cumulative treatment outcomes prevalence rates for patients in ART treatment from year 2020 to 2022 for study participant in Bauchi State. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Survival function analysis for LTFU according to Viral Load status and BMI status. by Ekerette Emmanuel Udoh (7326194)

Subjects:

Annual incidence rate per 100 person-years trend for ART treatment outcomes. by Ekerette Emmanuel Udoh (7326194)

Subjects: